Metraipolis › archive › dc_c865c6ebc8ef

Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities — Europe PMC PMID:40979393

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40979393
DOI
10.3389/fdsfr.2024.1356405
License (as archived)
solo-consultazione
Archived
2026-10-06T12:43:01.430Z
SHA-256 of the archived text
3d463d0cd1c2babf468f3565df277481507e7cb74b69de4e265477b9b3d80333
Stable URL of this page
https://metraipolis.com/documento/dc_c865c6ebc8ef

How to cite

Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities — Europe PMC PMID:40979393 — Europe PMC (en), https://europepmc.org/article/MED/40979393 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c865c6ebc8ef (Metraipolis archive dc_c865c6ebc8ef, sha256 3d463d0cd1c2babf468f3565df277481507e7cb74b69de4e265477b9b3d80333)
BibTeX
@misc{dcc865c6ebc8ef,
  title = {Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities — Europe PMC PMID:40979393},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40979393},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c865c6ebc8ef; sha256 3d463d0cd1c2babf468f3565df277481507e7cb74b69de4e265477b9b3d80333},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40979393. Agents can read the archived copy with the MCP tool read_document.